Celine Gongora
Montpellier, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
TopBP1 biomolecular condensates as a new therapeutic target in advanced-stage colorectal cancer.
Journal: eLife
Published: October 21, 2025
P38MAPK targeting in pancreatic ductal adenocarcinoma: Promising interventional approach for breaking drug resistance and tumor control.
Journal: Medical oncology (Northwood, London, England)
Published: October 08, 2025
Characterization of the cell-free DNA released by tumor organoids derived from colorectal cancer patients.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 25, 2025
Oxaliplatin, ATR inhibitor and anti-PD-1 antibody combination therapy controls colon carcinoma growth, induces local and systemic changes in the immune compartment, and protects against tumor rechallenge in mice.
Journal: Journal for immunotherapy of cancer
Published: March 01, 2025
Inhibiting microtubule polymerization with EAPB02303, a prodrug activated by catechol-O-methyl transferase, enhances paclitaxel effect in pancreatic cancer models.
Journal: Cell death & disease
Published: November 26, 2024
Targeting SUV4-20H Epigenetic Enzymes Enhances Topoisomerase II Poisoning in Prostate Cancer.
Journal: Cancer research
Published: October 24, 2024
Efficacy of novel allogeneic cancer cells vaccine to treat colorectal cancer.
Journal: Frontiers in oncology
Published: May 03, 2024
STING-ATF3/type I interferon crosstalk: A potential target to improve anti-tumour immunity in chemotherapy-treated urothelial carcinoma.
Journal: Clinical and translational medicine
Published: April 08, 2024
ATR inhibition potentiates FOLFIRINOX cytotoxic effect in models of pancreatic ductal adenocarcinoma by remodelling the tumour microenvironment.
Journal: British journal of cancer
Published: February 01, 2024
Last Updated: 09/26/2026